HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:
Guest Access | Sign In via User Name/Password

This Article Full Text Free Full Text (PDF) Free Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Article Archive Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (10) Citing Articles via Google Scholar Google Scholar Articles by Reickert, C. A. Articles by Hirschl, R. B. Search for Related Content PubMed PubMed Citation Articles by Reickert, C. A. Articles by Hirschl, R. B.

The Pulmonary and Systemic Distribution and Elimination of Perflubron From Adult Patients Treated With Partial Liquid Ventilation^*

^* From the Departments of Surgery (Drs. Reickert, Pranicoff, Overbeck, Bartlett, and Hirschl), Radiology (Dr. Kazerooni), and Anesthesia (Dr. Massey), University of Michigan Medical Center, Ann Arbor, MI.

Correspondence to: Ronald B. Hirschl, MD, FCCP, F3970 Mott Children’s Hospital, 1500 E. Medical Center Dr, Ann Arbor, MI 48109-0245; e-mail: rhirschl{at}umich.edu

Objective: To assess the pulmonary and systemic distribution and elimination of perflubron (C₈F₁₇Br₁; LiquiVent; Alliance Pharmaceutical; San Diego, CA) during and following the period of partial liquid ventilation.

Design: Prospective phase I and II clinical trial.

Setting: Adult surgical ICU.

Patients: Eighteen adult patients (mean ± SEM age, 37.9 ± 3.4 years) with severe respiratory failure, some of whom required extracorporeal life support (72%), and who were managed with partial liquid ventilation with perflubron.

Interventions: Perflubron was administered into the trachea, and gas ventilation of the perfluorocarbon-filled lung (partial liquid ventilation) was then performed. Additional doses were administered daily for from 1 to 7 days, with a median cumulative dose of 31 mL/kg (range, 3 to 60 mL/kg).

Measurements and main results: Patient blood samples were evaluated by gas chromatography for serum perflubron levels. Sequential lateral and anteroposterior radiographs were assessed, using a 5-point rating scale, for the degree of perflubron fill following the final dose. Samples of expired gas were collected, and the rate of loss of perflubron in the expired gas was measured by gas chromatography. Mean serum perflubron levels increased to 0.16 ± 0.05 mg/dL at 24 h following administration of the initial dose. A mean maximum level of 0.26 ± 0.05 mg/dL of perflubron was present in the serum 24 h following the administration of the last dose. This level slowly trended downward to 0.18 ± 0.06 mg/dL over the ensuing 7 days (p = 0.281). Perflubron elimination via expired gas occurred at a mean rate of 9.4 ± 3.0 mL/h at 1 h, and 1.0 ± 0.4 mL/h at 48 h after the last dose (p = 0.012). By radiologic evaluation, perflubron was eliminated from the lungs progressively from 4.2 ± 0.2 at the time of administration of the last dose, to 2.8 ± 0.3 at 4 days later (p < 0.001). Perflubron tended to distribute and remain for longer periods in the dependent regions of the lung when compared to the nondependent regions (96-h perflubron fill score: posterior, 3.8 ± 0.5; anterior, 1.9 ± 0.4; p = 0.004).

Conclusions: Perflubron is eliminated at a maximum rate of 9.4 ± 3.0 mL/h by evaporative loss from the airways and is retained in greater amounts in the dependent lung regions when compared to the nondependent lung regions. There is a low but measurable maximum blood concentration of 0.26 ± 0.05 mg/dL in patients after perflubron administration, which did not decrease significantly after cessation of partial liquid ventilation.

Key Words: partial liquid ventilation • perflubron • respiratory failure

This article has been cited by other articles:

				S.A. Loer, D. Kindgen-Milles, and J. Tarnow Partial liquid ventilation: effects of liquid volume and ventilatory settings on perfluorocarbon evaporation Eur. Respir. J., December 1, 2002; 20(6): 1499 - 1504. [Abstract] [Full Text] [PDF]